<p>在当前市场交易中，<strong>吉利德科学公司 (NASDAQ: GILD)</strong> 的股价为 147.00 美元，下降了 <strong>1.31%</strong>。然而，在过去一个月中，该公司的股价上涨了 <strong>4.93%</strong>，在过去一年中上涨了 <strong>28.42%</strong>。股东可能会对股票是否被高估感兴趣，即使该公司在当前交易中的表现不尽如人意。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="过去一年图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png"/></p>
<h3>评估吉利德科学的市盈率与同行的比较</h3>
<p>市盈率是长期股东用来评估公司市场表现的工具，通常与整体市场数据、历史收益和行业整体情况进行比较。较低的市盈率可能表明股东不期望该股票在未来表现更好，或者可能意味着公司被低估。</p>
<p>吉利德科学的市盈率低于生物技术行业整体市盈率 <strong>79.25</strong>。理想情况下，人们可能会认为该股票的表现会逊色于同行，但也有可能该股票被低估。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="仪表" width="700" height="500" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png"/></p>
<p>总之，尽管市盈率是投资者评估公司市场表现的有价值工具，但使用时应谨慎。低市盈率可能表明被低估，但也可能暗示增长前景疲弱或财务不稳定。此外，市盈率只是投资者在做出投资决策时应考虑的众多指标之一，应该与其他财务比率、行业趋势和定性因素一起评估。通过全面分析公司的财务健康状况，投资者可以做出更明智的决策，从而更有可能获得成功的结果。</p>

吉利德科学

<p>吉利德科学（Gilead Sciences Inc.，NASDAQ:GILD）股票目前价格为 147.00 美元，反映出下降 1.31%。尽管如此，该股票在过去一个月上涨了 4.93%，在过去一年上涨了 28.42%。公司的市盈率低于生物技术行业的平均水平 79.25，这表明可能被低估。然而，低市盈率也可能表明增长前景疲弱。投资者在做出投资决策之前，应考虑多个财务指标和定性因素，以进行全面分析</p>

<p>In the current market session, <strong>Gilead Sciences Inc. (NASDAQ: GILD)</strong> stock price is at $147.00, after a <strong>1.31%</strong> decrease. However, over the past month, the company's stock increased by <strong>4.93%</strong>, and in the past year, by <strong>28.42%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session.</p>
<div class="lb-trans"><p>在当前市场交易中，<strong>吉利德科学公司 (NASDAQ: GILD)</strong> 的股价为 147.00 美元，下降了 <strong>1.31%</strong>。然而，在过去一个月中，该公司的股价上涨了 <strong>4.93%</strong>，在过去一年中上涨了 <strong>28.42%</strong>。股东可能会对股票是否被高估感兴趣，即使该公司在当前交易中的表现不尽如人意。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png" alt="Past Year Chart" original-src="https://www.benzinga.com/files/images/story/2026/1772229633_0.png"/></p>
<h3>Evaluating Gilead Sciences P/E in Comparison to Its Peers</h3>
<div class="lb-trans"><h3>评估吉利德科学的市盈率与同行的比较</h3>
</div><p>The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued.</p>
<div class="lb-trans"><p>市盈率是长期股东用来评估公司市场表现的工具，通常与整体市场数据、历史收益和行业整体情况进行比较。较低的市盈率可能表明股东不期望该股票在未来表现更好，或者可能意味着公司被低估。</p>
</div><p>Gilead Sciences has a lower P/E than the aggregate P/E of <strong>79.25</strong> of the Biotechnology industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued.</p>
<div class="lb-trans"><p>吉利德科学的市盈率低于生物技术行业整体市盈率 <strong>79.25</strong>。理想情况下，人们可能会认为该股票的表现会逊色于同行，但也有可能该股票被低估。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png" alt="Guage" original-src="https://www.benzinga.com/files/images/story/2026/1772229633_1.png"/></p>
<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.</p>
<div class="lb-trans"><p>总之，尽管市盈率是投资者评估公司市场表现的有价值工具，但使用时应谨慎。低市盈率可能表明被低估，但也可能暗示增长前景疲弱或财务不稳定。此外，市盈率只是投资者在做出投资决策时应考虑的众多指标之一，应该与其他财务比率、行业趋势和定性因素一起评估。通过全面分析公司的财务健康状况，投资者可以做出更明智的决策，从而更有可能获得成功的结果。</p>
</div>

吉利德科学的市盈率分析